Tricida Inc (TCDAQ)

  • Get an in-depth profile of Tricida Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
0.007 0.000 (0.00%)
Closed USD Disclaimer

Tricida Inc Company Profile

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
57
Equity Type
ORD
On June 12, 2023, Tricida, Inc went out of business as per its Chapter 11 liquidation filing under bankruptcy. Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Contact Information
Address
South San Francisco,94080 United States
Phone
415 429 7800
Fax
-
Web
https://www.tricida.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.